CTOs on the Move

Akouos

www.akouos.com

 
Akouos is a precision genetic medicine company dedicated to developing gene therapies that restore and preserve hearing. Leveraging its adeno-associated viral (AAV) vector-based gene therapy platform, Akouos is focused on developing precision therapies for forms of sensorineural hearing loss. Headquartered in Boston, the Company was founded in 2016 by world leaders in the fields of neurotology, genetics, inner ear drug delivery, and AAV gene therapy. Akouos has strategic partnerships with Massachusetts Eye and Ear Infirmary and Lonza, Inc
  • Number of Employees: 25-100
  • Annual Revenue: $1-10 Million
  • www.akouos.com
  • 645 Summer Street Suite 200
    Boston, MA USA 02210
  • Phone: n/a

Executives

Name Title Contact Details
Stacy Price
 Chief Technical Officer Profile
Alan Smith
 Chief Technology Officer Profile
Alan Smith
 Chief Technology Officer Profile

Funding

Akouos raised $105M on 03/03/2020

Similar Companies

Abpro

We are a biotechnology company dedicated to developing next-generation antibody therapeutics to improve the lives of patients with severe and life-threatening diseases.

Nimbus Therapeutics

Nimbus Therapeutics is a biotechnology company headquartered in Cambridge, Massachusetts (USA).

Purigen Biosystems

Purigen Biosystems transformative platform provides a hands-free solution for extracting, enriching and quantifying DNA and RNA from biological samples.

Neurogene

Neurogene is accelerating development of new genetic medicines to people with devastating neurological diseases and their families.

ApoCell

ApoCell is a Houston, TX-based company in the Healthcare, Pharmaceuticals, and Biotech sector.